The UK’s health regulator has approved an oral version of the weight-loss drug semaglutide for prescription by doctors and pharmacists. This daily pill provides a more accessible alternative to injections for appetite regulation and could significantly expand treatment options for patients living with obesity.

Summary based on Malvern Gazette article